Richard Mattson, MD

Richard Mattson, MD, is recognized worldwide for his expertise in the diagnosis and treatment of epilepsy, which he describes as “a treatable condition with many neuroscientific insights. This disorder can be successfully managed in most patients.”

Dr. Mattson, who cares for both adult and pediatric patients, has contributed to making the Yale Medicine Epilepsy & Seizure Center a leader in research, education and treatment. He was the first doctor to report the use of sleep deprivation as an activating factor in epilepsy and the electroencephalogram; and one of the first to develop a continuous epilepsy monitoring unit. He directed the first and largest landmark clinical trial comparing anti-epileptic drugs.

He is a professor emeritus (neurology) at Yale School of Medicine and a senior research scientist in neurology currently focused on clinical case reports and anti-epileptic drug reviews. He has been the co-chair of the J. Kiffin Epilepsy Mini-Fellowship Program, which trains neurologists nationwide about epilepsy, for almost two decades. Dr. Mattson has been recognized as a Top Doctor in the state by Connecticut Magazine and is also the co-director of the epilepsy fellowship program at Yale.